Literature DB >> 14679452

Age distribution for T cell reactivity to vaccinia virus in a healthy population.

Szu-Min Hsieh1, Sung-Ching Pan, Shey-Ying Chen, Pei-Fang Huang, Shan-Chwen Chang.   

Abstract

The potential for bioterrorism involving smallpox has led to a debate about the durability of protective immunity against smallpox from vaccination. By assessing the T cell reactivity to vaccinia virus in a healthy population, we show that subjects who were vaccinated within the past 3 decades and who have a visible vaccination scar had remarkable T cell reactivity. However, person who were vaccinated within the past 3 decades but who do not have a scar and those who were vaccinated >4 decades ago had responses as low as those in unvaccinated subjects. Thus, we estimate that the significant T cell memory response to vaccinia virus from successful vaccination may persist for only 20-30 years. Furthermore, we found the vaccinia-specific cellular immunity could be easily assessed by determination of the frequencies of vaccinia-specific CD69 expression on T cell subsets. These data may help in the development of public health strategies to counter bioterrorism threats associated with smallpox.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14679452     DOI: 10.1086/380460

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  6 in total

1.  Immunological memory after exposure to variola virus, monkeypox virus, and vaccinia virus.

Authors:  Sumathi Sivapalasingam; Jeffrey S Kennedy; William Borkowsky; Fred Valentine; Ming-Xia Zhan; Pamela Pazoles; Anna Paolino; Francis A Ennis; Neal H Steigbigel
Journal:  J Infect Dis       Date:  2007-03-05       Impact factor: 5.226

2.  Immunity from smallpox vaccine persists for decades: a longitudinal study.

Authors:  Dennis D Taub; William B Ershler; Mark Janowski; Andrew Artz; Michael L Key; Julie McKelvey; Denis Muller; Bernard Moss; Luigi Ferrucci; Patricia L Duffey; Dan L Longo
Journal:  Am J Med       Date:  2008-12       Impact factor: 4.965

Review 3.  OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory viruses.

Authors:  John Goulding; Vikas Tahiliani; Shahram Salek-Ardakani
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

Review 4.  Capripoxvirus Infections in Ruminants: A Review.

Authors:  Jihane Hamdi; Henry Munyanduki; Khalid Omari Tadlaoui; Mehdi El Harrak; Ouafaa Fassi Fihri
Journal:  Microorganisms       Date:  2021-04-23

5.  Logistics of community smallpox control through contact tracing and ring vaccination: a stochastic network model.

Authors:  Travis C Porco; Karen A Holbrook; Susan E Fernyak; Diane L Portnoy; Randy Reiter; Tomás J Aragón
Journal:  BMC Public Health       Date:  2004-08-06       Impact factor: 3.295

6.  Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV.

Authors:  Galileu Barbosa Costa; Lídia Teodoro Santos Augusto; Juliana Almeida Leite; Paulo César Peregrino Ferreira; Cláudio Antônio Bonjardim; Jônatas Santos Abrahão; Erna Geessien Kroon; Elizabeth Castro Moreno; Giliane de Souza Trindade
Journal:  Virol J       Date:  2016-07-04       Impact factor: 4.099

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.